June 18, 2009-Thirteen new Organizations earned accreditation from the Association for the Accreditation of Human Research Protection Programs (AAHRPP) a week ago, including two that joined others from their university systems.
The University of Texas Health Science Center at Houston and The University of Texas Health Science Center at San Antonio are joining the University of Texas at Austin as newly Accredited Organizations. And the University of California, Los Angeles, joins three others in the University of California System-Irvine, San Francisco, and Riverside-on the accredited roster as well.
In addition, one major teaching hospital and another independent children’s hospital joined the ranks of Organizations like theirs at AAHRPP, which has now accredited 188 Organizations with more than 900 entities.
The Organizations, all awarded Full Accreditation, are:
Beth Israel Deaconess Medical Center, Boston, MA
G.V. (Sonny) Montgomery VAMC, Jackson, MS
Louisiana State University Health Sciences Center – Shreveport, Shreveport, LA
Nationwide Children’s Hospital, Columbus, OH
Overton Brooks VA Medical Center, Shreveport, LA
South Texas Veterans Health Care System, San Antonio, TX
Southeast Louisiana Veterans Healthcare System, New Orleans, LA
Syracuse VA Medical Center, Syracuse, NY
The University of Colorado Denver, Denver, CO
The University of Texas Health Science Center at Houston, Houston, TX
The University of Texas Health Science Center at San Antonio, San Antonio, TX
University of California, Los Angeles, Los Angeles, CA
VA Eastern Colorado Health Care System, Denver, CO
AAHRPP is a non-profit organization that works with Organizations that conduct human research to raise the level of protection for research participants. AAHRPP accredits Organizations that can demonstrate they provide participant safeguards that surpass the threshold of state and federal requirements. The accreditation program utilizes a voluntary, peer-driven educational model. For organizations interested in learning more about accreditation, visit http://www.aahrpp.org/
Through the rigorous accreditation process, Organizations must demonstrate that they have built extensive safeguards into every level of their research operation and that they adhere to the highest standards for research. AAHRPP’s standards exceed federal regulations by requiring Organizations to address conflict of interest, to provide community outreach and education and to apply the same stringent protections to all research involving human participants. (Under federal regulations, such protections are mandated only for federally sponsored or regulated research.) The accreditation process typically results in system-wide improvements that enhance protections for research participants and promote high-quality research.
Accreditation is available to Organizations worldwide that conduct biomedical, behavioral or social sciences research involving human participants. Decisions on accreditation are announced quarterly, and accreditation is valid for three years.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.